Return Peptide Library
Exenatide
BLevel 1 evidenceExenatide
GLP-1 and incretin receptor agonists
Basic Information
Categories
GLP-1 receptor agonist
Overview
The first GLP-1 receptor agonist, derived from the venom of the Gila monster.
Efficacy Rating
Metabolic health, FDA-approved, GLP-1
Evidence Level
Grade B
Evidence Type
No data available
Confidence
No data available
China Regulatory Status
Cosmetic Ingredient Directory
No data available
Food/Supplements
No data available
Medicine
No data available
Similar Peptide Recommendations
Albiglutide
Albiglutide
BGLP-1 and incretin receptor agonists
GLP-1 RA, type 2 diabetes mellitus, discontinued
Semaglutide
Ecenoglutide
BGLP-1 and incretin receptor agonists
GLP-1, weight loss, biased agonist
Enisamitide
Enisamipide
BGLP-1 and incretin receptor agonists
GLP-1/GIP agonist, weight loss
Mazdutide
Mazdutide
BGLP-1 and incretin receptor agonists
GLP-1/Glucagon-like Receptor Agonists for Weight Loss
Disclaimer
The content on this platform is for educational and informational purposes only and does not constitute medical advice, formulation guidance, or a guarantee of regulatory compliance. All efficacy claims are labeled with their evidence level; please consult a professional before making any decisions.